Identification and Optimization of cell active 4-anilino-quin(az)oline Inhibitors for Protein Kinase Novel 3 (PKN3)
Asquith, C. R. M.; Temme, L.; Laitinen, T.; Pickett, J.; Kwarcinski, F. E.; Sinha, P.; Wells, C. I.; Tizzard, G. J.; Zutshi, R.; Drewry, D. H.
Show abstract
The development of a small library of 4-anilinoquinolines led to the identification of 7-iodo-N-(3,4,5-trimethoxyphenyl)quinolin-4-amine 16 as a potent inhibitor of Protein Kinase Novel 3 (PKN3) with an IC50 of 1.3 M in cells. Compound 16 presents a useful potential tool compound to study the biology of PKN3 including links to pancreatic and prostate cancer, along with T-cell acute lymphoblastic leukemia. These compounds may be useful tools to explore the therapeutic potential of PKN3 inhibition in prevention of a broad range of infectious and systemic diseases.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.